Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2

References

• Brenner H, Kloor M, and Pox CP: Colorectal cancer. Lancet 383(9927), 1490–1502, 2014.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI: Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 35(2), 229–244, 2013.
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, and Karin M: Inflammation and colon cancer. Gastroenterology 138(6), 2101–2114e5, 2010.
   PubMed Web of Science ®Google Scholar
• Arthur JC and Jobin C: The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes 4(3), 253–258, 2013.
   PubMed Web of Science ®Google Scholar
• Takeuchi O and Akira S: Pattern recognition receptors and inflammation. Cell 140(6), 805–820, 2010.
   PubMed Web of Science ®Google Scholar
• Omrane I and Benammar-Elgaaied A: The immune microenvironment of the colorectal tumor: involvement of immunity genes and microRNAs belonging to the TH17 pathway. Biochim Biophys Acta 1856(1), 28–38, 2015.
   PubMed Web of Science ®Google Scholar
• Branquinho D, Freire P, and Sofia C: NOD2 mutations and colorectal cancer—Where do we stand? World J Gastrointest Surg 8(4), 284–293, 2016.
   PubMed Web of Science ®Google Scholar
• Tsai WH, Huang DY, Yu YH, Chen CY, and Lin WW: Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages. Cell Microbiol 13(5), 717–730, 2011.
   PubMed Web of Science ®Google Scholar
• Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, et al.: Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. Gut doi:10.1136/gutjnl-2015-310382
   Web of Science ®Google Scholar
• Fernandez-Garcia B, Eiro N, Gonzalez-Reyes S, Gonzalez L, Aguirre A, Gonzalez LO, et al.: Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother 37(2), 77–83, 2014.
   PubMed Web of Science ®Google Scholar
• Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, et al.: Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131(3), 862–877, 2006.
   PubMed Web of Science ®Google Scholar
• Pericleous M, Mandair D, and Caplin ME: Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol 4(4), 409–423, 2013.
   PubMedGoogle Scholar
• Dalberg J, Jacobsen O, Nielsen NH, Steig BA, and Storm HH: Colorectal cancer in the Faroe Islands–a setting for the study of the role of diet. J Epidemiol Biostat 4(1), 31–36, 1999.
   PubMedGoogle Scholar
• Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al.: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32(3), 210–216, 2007.
   PubMed Web of Science ®Google Scholar
• Chandler PD, Buring JE, Manson JE, Giovannucci EL, Moorthy MV, Zhang S, et al.: Circulating vitamin D levels and risk of colorectal cancer in women. Cancer Prev Res (Phila) 8(8), 675–682, 2015.
   PubMed Web of Science ®Google Scholar
• Barragan M, Good M, and Kolls JK: Regulation of dendritic cell function by vitamin D. Nutrients 7(9), 8127–8151, 2015.
   PubMed Web of Science ®Google Scholar
• Diaz L, Diaz-Munoz M, Garcia-Gaytan AC, and Mendez I: Mechanistic effects of calcitriol in cancer biology. Nutrients 7(6), 5020–5050, 2015.
   PubMed Web of Science ®Google Scholar
• Raman M, Milestone AN, Walters JR, Hart AL, and Ghosh S: Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Ther Adv Gastroenterol 4(1), 49–62, 2011.
   PubMedGoogle Scholar
• Ooi JH, Li Y, Rogers CJ, and Cantorna MT: Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 143(10), 1679–1686, 2013.
   PubMed Web of Science ®Google Scholar
• Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al.: Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285(4), 2227–2231, 2010.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, et al.: Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 12, 57, 2012.
   PubMed Web of Science ®Google Scholar
• Dimitrov V and White JH: Species-specific regulation of innate immunity by vitamin D signaling. J Steroid Biochem Mol Biol. 164, 246–253, 2016.
   Web of Science ®Google Scholar
• Dionne S, Calderon MR, White JH, Memari B, Elimrani I, Adelson B, et al.: Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease. Mucosal Immunol 7(6), 1405–1415, 2014.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, et al.: Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 12(5), 821–827, 2014.
   PubMed Web of Science ®Google Scholar
• De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, et al.: The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog 10, 9, 2011.
   PubMedGoogle Scholar
• Cooper HS, Murthy SN, Shah RS, and Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69(2), 238–249, 1993.
   PubMed Web of Science ®Google Scholar
• Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, et al.: Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124(3), 762–777, 2003.
   PubMed Web of Science ®Google Scholar
• Koszewski NJ, Horst RL, and Goff JP: Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colon. Am J Physiol Gastrointest Liver Physiol 303(7), G870–G878, 2012.
   PubMed Web of Science ®Google Scholar
• Chow EC, Quach HP, Vieth R, and Pang KS: Temporal changes in tissue 1alpha,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Am J Physiol Endocrinol Metab 304(9), E977–E989, 2013.
   PubMed Web of Science ®Google Scholar
• Afrazi A, Sodhi CP, Good M, Jia H, Siggers R, Yazji I, et al.: Intracellular heat shock protein-70 negatively regulates TLR4 signaling in the newborn intestinal epithelium. J Immunol 188(9), 4543–4557, 2012.
   PubMed Web of Science ®Google Scholar
• Robertson SJ, Zhou JY, Geddes K, Rubino SJ, Cho JH, Girardin SE, et al.: Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4(3), 222–231, 2013.
   PubMed Web of Science ®Google Scholar
• Mirpuri J, Sotnikov I, Myers L, Denning TL, Yarovinsky F, Parkos CA, et al.: Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. PLoS One 7(12), e51955, 2012.
   PubMed Web of Science ®Google Scholar
• Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, et al.: Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog 9(6), e1003407, 2013.
   PubMed Web of Science ®Google Scholar
• Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402–408, 2001.
   PubMed Web of Science ®Google Scholar
• DeLuca HF: Evolution of our understanding of vitamin D. Nutr Rev 66(10 Suppl 2), S73–S87, 2008.
   PubMed Web of Science ®Google Scholar
• Lips P and van Schoor NM: The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25(4), 585–591, 2011.
   PubMed Web of Science ®Google Scholar
• Bouillon R, Carmeliet G, Lieben L, Watanabe M, Perino A, Auwerx J, et al.: Vitamin D and energy homeostasis: of mice and men. Nat Rev Endocrinol 10(2), 79–87, 2014.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Munsick C, Bemiss C, and Mahon BD: 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130(11), 2648–2652, 2000.
   PubMed Web of Science ®Google Scholar
• Goff JP, Koszewski NJ, Haynes JS, and Horst RL: Targeted delivery of vitamin D to the colon using beta-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302(4), G460–G469, 2012.
   PubMed Web of Science ®Google Scholar
• Murillo G, Nagpal V, Tiwari N, Benya RV, and Mehta RG: Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J Steroid Biochem Mol Biol 121(1–2), 403–407, 2010.
   PubMed Web of Science ®Google Scholar
• Xu Y, Hashizume T, Shuhart MC, Davis CL, Nelson WL, Sakaki T, et al.: Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol 69(1), 56–65, 2006.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, et al.: Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 123(9), 3983–3996, 2013.
   PubMed Web of Science ®Google Scholar
• Klampfer L: Vitamin D and colon cancer. World J Gastrointest Oncol 6(11), 430–437, 2014.
   PubMed Web of Science ®Google Scholar
• Giardina C, Nakanishi M, Khan A, Kuratnik A, Xu W, Brenner B, et al.: Regulation of VDR expression in Apc-mutant mice, human colon cancers and adenomas. Cancer Prev Res (Phila) 8(5), 387–399, 2015.
   PubMed Web of Science ®Google Scholar
• Glenn AJ, Fielding KA, Chen J, Comelli EM, and Ward WE: Long-term vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in IL-10 knockout mice at young adulthood. Nutrients 6(9), 3847–3862, 2014.
   PubMed Web of Science ®Google Scholar
• Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, et al.: NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123(2), 700–711, 2013.
   PubMed Web of Science ®Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, et al.: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307(5710), 731–734, 2005.
   PubMed Web of Science ®Google Scholar
• Li CP, Li JH, He SY, Chen O, and Shi L: Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis. Genet Mol Res 14(2), 3450–3458, 2015.
   PubMed Web of Science ®Google Scholar
• Roelofs HM, Te Morsche RH, van Heumen BW, Nagengast FM, and Peters WH: Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol 14, 1, 2014.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, and Balkwill F: Cancer-related inflammation. Nature 454(7203), 436–444, 2008.
   PubMed Web of Science ®Google Scholar
• Liu X, Nelson A, Wang X, Farid M, Gunji Y, Ikari J, et al.: Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts. Am J Respir Cell Mol Biol 50(1), 40–50, 2014.
   PubMed Web of Science ®Google Scholar
• Wang Q, He Y, Shen Y, Zhang Q, Chen D, Zuo C, et al.: Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. J Biol Chem 289(17), 11681–11694, 2014.
   PubMed Web of Science ®Google Scholar
• Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342(26), 1946–1952, 2000.
   PubMed Web of Science ®Google Scholar
• Gupta RA and Dubois RN: Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1(1), 11–21, 2001.
   PubMed Web of Science ®Google Scholar
• Oshima M and Taketo MM: COX selectivity and animal models for colon cancer. Curr Pharm Des 8(12), 1021–1034, 2002.
   PubMed Web of Science ®Google Scholar
• Ishikawa TO and Herschman HR: Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis 31(4), 729–736, 2010.
   PubMed Web of Science ®Google Scholar
• Guslandi M: Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction? World J Gastroenterol 12(10), 1509–1510, 2006.
   PubMed Web of Science ®Google Scholar
• Froicu M, Zhu Y, and Cantorna MT: Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117(3), 310–318, 2006.
   PubMed Web of Science ®Google Scholar
• Wobke TK, Sorg BL, and Steinhilber D: Vitamin D in inflammatory diseases. Front Physiol 5, 244, 2014.
   PubMed Web of Science ®Google Scholar
• Lopetuso LR, Chowdhry S, and Pizarro TT: Opposing functions of classic and novel IL-1 family members in gut health and disease. Front Immunol 4, 181, 2013.
   PubMed Web of Science ®Google Scholar
• Voronov E and Apte RN: IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer. Cancer Microenviron 8(3), 187–200, 2015.
   PubMed Web of Science ®Google Scholar
• Nonn L, Peng L, Feldman D, and Peehl DM: Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res 66(8), 4516–4524, 2006.
   PubMed Web of Science ®Google Scholar
• Daniel C, Sartory NA, Zahn N, Radeke HH, and Stein JM: Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324(1), 23–33, 2008.
   PubMed Web of Science ®Google Scholar